English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17905/22920 (78%)
Visitors : 7531495      Online Users : 262
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23188


    Title: 冠狀動脈疾病與PCSK9之基因多型性研究
    Study on coronary artery disease and polymorphism of PCSK9
    Authors: 江世民
    Shih-Min Chiang
    Contributors: 醫學院:醫學研究所;楊順發(Shun-Fa Yang);翁國昌(Kwo-Chang Ueng)
    Keywords: 冠狀動脈疾病;前蛋白轉化?枯草溶菌素/ kexin 9型 (proprotein convertase subtilisin/kexin type 9 gene;PCSK9)
    Coronary artery disease (CAD);proprotein convertase subtilisin/kexin type 9 gene (PCSK9)
    Date: 2021-07-01
    Issue Date: 2022-08-01T10:25:20Z (UTC)
    Abstract: 冠狀動脈疾病是全球死亡率和發病率的主要原因。對於前蛋白轉化?枯草溶菌素/ kexin 9型 (proprotein convertase subtilisin/kexin type 9 gene;PCSK9) 基因的變異是否為冠狀動脈疾病的危險因素,其相關研究提供了有爭議性的結果。在我們的研究中,我們評估了台灣人群中,危險因子與PCSK9基因型和冠狀動脈疾病的相關性。因此,我們納入了501位經由血管攝影檢查診斷為冠狀動脈疾病患者,與334位沒有患有冠狀動脈疾病的對照。本研究進行了PCSK9 rs505151以及rs529787的兩個單一核?酸基因多形性進行基因分型。結果發現,攜帶PCSK9 rs505151 AG+GG基因型者,有冠狀動脈疾病家族史的人其患病率顯著更高。另外,在有冠狀動脈疾病家族史的患者中,相較於攜帶PCSK9 rs505151 AA基因型者 (39.2%),攜帶有AG+GG基因型者 (73.3%) 其糖尿病患病率也有顯著較高的現象。總而言之,攜帶有PCSK9 rs505151 AG基因型者的冠狀動脈疾病患者與糖尿病以及冠狀動脈疾病家族史有相關。
    URI: https://etds.csmu.edu.tw/ETDS/Home/Detail/U0003-3007202116021700
    https://dx.doi.org/10.6834/csmu202100184
    https://hdl.handle.net/11296/y29zxs
    https://ir.csmu.edu.tw:8080/handle/310902500/23188
    Appears in Collections:[醫學研究所] 博碩士論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML253View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback